Pharmaceuticals · Market statistics

Alzheimer Drugs market statistics

Size and growth in 33 countries and regions, with clinical trials and research from public sources.

Largest countries

Market size in 2023 · growth a year to 2033

  1. 1 Kenya $3.5 Bn 7.9% a year
  2. 2 US $2.1 Bn 4.8% a year
  3. 3 China $403 Mn 8.3% a year
  4. 4 Canada $401 Mn 6.8% a year
  5. 5 Japan $311 Mn 7.3% a year
  6. 6 Germany $183 Mn 5% a year
  7. 7 France $138 Mn 5.8% a year
  8. 8 UK $130 Mn 4.8% a year
  9. 9 Brazil $125 Mn 7.8% a year
  10. 10 Italy $120 Mn 6.3% a year

Most clinical trials

Active trials by country (ClinicalTrials.gov)

  1. 1 US 431
  2. 2 China 148
  3. 3 France 98
  4. 4 Canada 81
  5. 5 Spain 75
  6. 6 Italy 72
  7. 7 UK 64
  8. 8 Australia 44
See every trial on ClinicalTrials.gov (opens in a new tab)

Alzheimer Drugs by country and region

Alzheimer Drugs market size, growth and active trials in every geography we cover
Place20232033 (projected)CAGR Active trialsReport
World – – – 1,014 Report on Alzheimer Drugs in Global
North America $2.5 Bn $4.4 Bn 5.8% 472 Report on Alzheimer Drugs in North America
Europe $952 Mn $1.6 Bn 5.5% 242 Report on Alzheimer Drugs in Europe
APAC $441 Mn $967 Mn 8.2% 211 Report on Alzheimer Drugs in APAC
Latin America $225 Mn $478 Mn 7.8% 24 Report on Alzheimer Drugs in Latin America
Middle East $200 Mn $425 Mn 7.8% 5 Report on Alzheimer Drugs in Middle East
Africa $75 Mn $167 Mn 8.3% 1 Report on Alzheimer Drugs in Africa
Kenya $3.5 Bn $7.5 Bn 7.9% 0 Report on Alzheimer Drugs in Kenya
US $2.1 Bn $3.4 Bn 4.8% 431 Report on Alzheimer Drugs in US
China $403 Mn $894 Mn 8.3% 148 Report on Alzheimer Drugs in China
Canada $401 Mn $774 Mn 6.8% 81 Report on Alzheimer Drugs in Canada
Japan $311 Mn $630 Mn 7.3% 43 Report on Alzheimer Drugs in Japan
Germany $183 Mn $299 Mn 5% 39 Report on Alzheimer Drugs in Germany
France $138 Mn $242 Mn 5.8% 98 Report on Alzheimer Drugs in France
UK $130 Mn $208 Mn 4.8% 64 Report on Alzheimer Drugs in UK
Brazil $125 Mn $265 Mn 7.8% 19 Report on Alzheimer Drugs in Brazil
Italy $120 Mn $222 Mn 6.3% 72 Report on Alzheimer Drugs in Italy
Ecuador $100 Mn $205 Mn 7.4% 0 Report on Alzheimer Drugs in Ecuador
Spain $97 Mn $170 Mn 5.8% 75 Report on Alzheimer Drugs in Spain
India $91 Mn $232 Mn 9.8% 7 Report on Alzheimer Drugs in India
Saudi Arabia $85 Mn $189 Mn 8.3% 2 Report on Alzheimer Drugs in Saudi Arabia
Mexico $75 Mn $149 Mn 7.1% 12 Report on Alzheimer Drugs in Mexico
Australia $60 Mn $133 Mn 8.3% 44 Report on Alzheimer Drugs in Australia
South Africa $33 Mn $71 Mn 8% 0 Report on Alzheimer Drugs in South Africa
UAE $25 Mn $53 Mn 7.8% 3 Report on Alzheimer Drugs in UAE
Egypt $14 Mn $31 Mn 8.3% 1 Report on Alzheimer Drugs in Egypt
Philippines $11 Mn $22 Mn 7.3% 1 Report on Alzheimer Drugs in Philippines
Malaysia $8 Mn $16 Mn 7% 1 Report on Alzheimer Drugs in Malaysia
Hong Kong $8 Mn $17 Mn 7.8% 9 Report on Alzheimer Drugs in Hong Kong
Singapore $6 Mn $12 Mn 7.4% 10 Report on Alzheimer Drugs in Singapore
Thailand $6 Mn $12 Mn 7.1% 1 Report on Alzheimer Drugs in Thailand
New Zealand – – – 4 Report on Alzheimer Drugs in New Zealand
Russia – – – 3 Report on Alzheimer Drugs in Russia

"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.

Latest research 30,474 papers since 2021

  1. Tectoridin Attenuates Alzheimer's Pathology by Inhibiting Aβ Aggregation in 3xTg-AD Mice. European journal of pharmacology, 2026
  2. Effects of Probiotics/Synbiotic Interventions on Cognitive Dysfunction in Alzheimer's or MCI: A Systematic Review and Meta‑Analysis of randomized controlled trials. Ageing research reviews, 2026
  3. Possible therapeutic effects of native ADMSCs versus CSF preconditioned ADMSCs against colchicine-induced hippocampal damage in Wistar rats. Tissue & cell, 2026
  4. Critical advances and translational bottlenecks of gut microbiota-gut-brain axis targeted therapy for neurodegenerative and neurodevelopmental disorders. Journal of neuroimmunology, 2026
  5. Effects of Supplementation With Genistein on the Progression of Cognitive Decline in Patients With Mild Cognitive Impairment Due to Alzheimer Disease: Protocol for a Randomized Controlled Trial. JMIR research protocols, 2026
Search all of them on PubMed (opens in a new tab)

Compare Alzheimer Drugs side by side

Key companies in Alzheimer Drugs

AbbVie Novartis AG Biogen Inc. H. Lundbeck A/S Otsuka Pharmaceutical Co., Ltd. F. Hoffmann-La Roche AG Eli Lilly and Company

Quick answers

Which country has the largest Alzheimer Drugs market?

Kenya is the largest of the 24 countries we cover, at $3.5 Bn in 2023. India grows fastest, at 9.8% a year.

How many clinical trials are running in Alzheimer Drugs?

ClinicalTrials.gov lists 1,014 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.

How much research is published on Alzheimer Drugs?

PubMed lists about 30,474 papers on the topic since 2021.

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.

Get a free sample The global Alzheimer Drugs report: contents and sample pages, free. Request sample Consult us Need Alzheimer Drugs numbers for your plan? Our analysts can help. Talk to us Buy the report The full global report, $4,000. Every country report is in the table above. Buy now

All market statistics